One of the nation’s largest wholesale mortgage lenders reported a significant insider sale amid a year of declining share prices.Mat Ishbia, President and CEO of UWM Holdings Corporation (UWMC 3.75%), reported the indirect sale of 1,898,622 shares of Common Stock across three open-market transactions from Feb. 10 through Feb. 12, 2026, for nearly $9 million as disclosed in the SEC Form 4 filing. Transaction summaryMetricValueShares sold (indirect)1,898,622Transaction value$8,999,468 millionPost-transaction ...

Company Overview - Kirby Corporation is a leading U.S. provider of marine transportation and specialized distribution services, operating one of the largest fleets of tank barges and towboats in the country [7] - The company reported a revenue of $3.36 billion and a net income of $354.52 million for the trailing twelve months (TTM) [4] - Kirby's stock has experienced a 1-year price change of 21.20% as of February 22, 2026, and has seen five consecutive years of annual growth [4][8] Recent Developments - On February 10, 2026, Scott P. Miller, Vice President and Chief Investment Officer, sold 3,960 common shares for approximately $478,000, which accounted for 52.62% of his direct ownership [1][6] - Following the transaction, Miller retains 3,565 shares of common stock directly held [6] Market Position - Kirby operates in an industry that is essential for the energy and industrial sectors, providing transportation services relied upon by major tech, petroleum, cargo shipping, and automobile companies [9][10] - The company is recognized as America's largest operator of tank barges, primarily transporting materials such as petrochemicals and refined petroleum products [10] Financial Performance - Kirby's strong Q4 FY 2025 earnings exceeded EPS estimates, posting $1.68, marking the best performance in a quarter [8] - The stock has already increased by 18% in the year as of February 21, 2026 [8]

Core Insights - AnaptysBio reported a significant insider sale by Director J. Anthony Ware, who sold 3,900 shares for $193,342.50, representing 28.82% of his direct holdings, during a period of strong share price gains [1][2][10] Company Overview - AnaptysBio is a clinical-stage biotechnology company focused on developing antibody therapies for inflammatory and immune-mediated diseases [8] - The company has a market capitalization of $1.39 billion and reported revenue of $169.47 million for the trailing twelve months (TTM) [4] - The stock price increased by 264.63% over the past year, significantly outperforming the S&P 500's 17% gain [4][11] Transaction Details - The transaction involved a sale of 3,900 shares at a price of $49.58, with a post-transaction value of $481,885.20 based on the market close of $50.04 [2][4] - Post-transaction, Ware retains 9,630 shares and has options to purchase an additional 126,085 shares, along with 6,030 restricted stock units, indicating continued economic alignment with the company [10] Context of the Sale - This sale marks Ware's first open-market transaction at AnaptysBio, contrasting with previous administrative filings, suggesting a strategic decision rather than a shift in outlook [6][10] - The timing of the sale coincided with a high stock price following a substantial one-year return, indicating that the sale was likely a portfolio management decision [6][11] Company Performance - AnaptysBio reported $256.7 million in cash and investments at the end of the third quarter, with collaboration revenue increasing to $76.3 million from $30 million a year earlier [11] - The company's strong balance sheet and revenue visibility support the underlying investment thesis despite insider selling [11]

Core Viewpoint - The recent insider sale by CEO James S. Mahan of Live Oak Bancshares does not indicate a negative outlook for the company, as he retains significant indirect holdings and the company shows solid financial performance [7][9]. Company Overview - Live Oak Bancshares is a regional bank holding company focused on commercial banking for small business clients, generating revenue through net interest income and fee-based income from various financial services [6]. Insider Transaction Details - CEO James S. Mahan sold 10,000 shares at approximately $351,300 on December 12, 2025, through indirect holdings [6]. - The sale price of around $35.13 per share was slightly below the stock's closing price of $35.31 on December 12, 2025, and occurred during a period when the stock had a one-year total return of -19.97% [2]. - This transaction reduced Mr. Mahan's total and indirect holdings by 0.32%, leaving him with over six million shares held indirectly across various trusts and LLCs [3][7]. Market Context - The sale occurred when Live Oak Bancshares stock was experiencing an upswing, with the sale price close to the 52-week high of $41.56 reached in January 2025, suggesting Mr. Mahan was capitalizing on the rise in share price [8]. - The company's third-quarter revenue grew by 2% year over year to $146.1 million, with total assets increasing by 16% year over year to $14.67 billion, driven by strong loan production and deposit growth [9].

Core Insights - UWM Holdings, the largest wholesale mortgage lender in America, experienced a significant insider sale by CEO Mat Ishbia amid declining share prices [1][8] - Ishbia sold 1,224,574 Class A Common shares for approximately $6.8 million, representing a 23.39% reduction in his total pre-transaction holdings [2][6] - The company's stock has decreased by 10.90% over the past year, with a notable decline following a lawsuit against it [4][10] Company Overview - UWM Holdings specializes in residential mortgage loans, primarily through a wholesale lending channel, focusing on conforming and government-backed loans [5][7] - The company reported a total revenue of $1.37 billion and a net income of $16.89 million for the trailing twelve months [4] - UWM Holdings has a dividend yield of 6.08%, which may indicate a potential dividend trap [4][10] Transaction Details - The shares were sold at a weighted average price of $5.55, with the stock closing at $5.12 on December 12, 2025 [2][6] - Post-transaction, Ishbia retains 279,989 direct shares and 3,730,973 indirect shares [2][6] - The sale is consistent with Ishbia's historical trading patterns, aimed at increasing the stock's public float to attract institutional investors [8][9] Market Context - UWM's Q3 loan origination volume increased to $41.7 billion from $39.5 billion in 2024, contributing to revenue growth [10] - Despite the growth, the stock price fell after a lawsuit was not dismissed, raising concerns among investors [10][11] - The ongoing sales by Ishbia do not necessarily indicate a loss of confidence in the company, as he continues to hold a substantial number of shares [8][9]

Core Insights - Christopher Kalnin, CEO of BKV Corporation, sold 78,281 shares in an open-market transaction valued at $2.2 million, representing approximately 6% of his direct holdings [2][4][3] - The sale was executed under a pre-set Rule 10b5-1 trading plan, indicating routine activity rather than discretionary timing [8] - Following the sale, Kalnin retains about 1.2 million shares with an aggregate market value of $35 million [6][3] Transaction Summary - Shares sold: 78,281 - Transaction value: $2.2 million - Post-transaction shares (direct): 1,248,580 - Post-transaction value (direct): $35 million - Sale price per share: $28.04; post-transaction closing price: $28.02 [3] Company Overview - Market capitalization: $2.3 billion - Revenue (TTM): $809 million - Net income (TTM): $45.3 million - 1-year price change: 20% - BKV Corporation focuses on natural gas exploration, production, and midstream operations [7] Performance Insights - BKV reported $76.9 million in net income last quarter, driven by higher production volumes and improved gathering margins [10] - The company is experiencing rising production but negative free cash flow, with a significant increase in capital expenditures year over year [8][10] - Despite a recent 9% decline, the stock is still up over 20% over the past year, indicating strong long-term performance [11]